Vaccination schedule for adolescents. Consensus of the AEV, CAV-AEP and SEMAArticle Published on 2023-08-312024-09-09 Journal: An Pediatr (Engl Ed) [Category] 백일해, [키워드] Adolescent Adolescente Calendario de inmunización grupos de riesgo immunization schedule risk groups Vaccines vacunas PMC 바로가기
Temporal and spatial distribution trends of polio vaccine coverage in less than one-year old children in Brazil, 2011–2021브라질에서 2011–2021년 사이 1세 미만 아동의 폴리오 백신 접종의 시간적 및 공간적 분포 경향Article Published on 2023-07-142024-07-28 Journal: BMC Public Health [Category] 폴리오, [키워드] Brazil Ecological studies immunization programs immunization schedule Poliovirus Vaccines Spatial analysis [DOI] 10.1186/s12889-023-16192-8 PMC 바로가기
Review of scientific evidence to support recommendations of the full-dose DTaP-IPV vaccination in pre-school age children in Italy이탈리아 미취학 아동의 DTaP-IPV 접종 권장 사항을 뒷받침하는 과학적 증거 검토Article Published on 2022-12-012024-07-28 Journal: Expert review of vaccines [Category] 백일해, 파상풍, [키워드] Adolescence children DTaP-IPV full dose immunization schedule pre-school booster vaccination coverage Vaccine [DOI] 10.1080/14760584.2022.2130770
Comparison of immune responses induced by two or three doses of an alum-adjuvanted inactivated SARS-CoV-2 vaccine in mice마우스에서 명반 면역증강제가 첨가된 비활성화 SARS-CoV-2 백신의 2~3회 투여에 의해 유도된 면역 반응의 비교Article Published on 2022-05-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Adjusting alum alum-adjuvanted inactivated SARS-CoV-2 vaccine Analysis antibody BNT162b2 boost CD4+ CD8+ Cell-mediated immunity cellular cellular immunity clinical trials coronavirus dose doses Heterologous homologous humoral Humoral response humoral responses IgG responses immune response immune responses immunization immunization schedule immunization schedules inactivated memory mice offer respiratory response SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV-2 vaccines second dose severe acute respiratory syndrome Coronavirus significantly spike-specific cellular immunity spike-specific IgG T cell T cell response tested Th2 Vaccine development variant [DOI] 10.1002/jmv.27637 PMC 바로가기 [Article Type] Article
A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity2개의 재조합 이량체 RBD COVID-19 백신 후보에 대한 무작위 이중 맹검 1상 임상 시험: 안전성, 반응성 및 면역원성Clinical Trial Published on 2022-03-182022-09-12 Journal: Vaccine [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] adjuvants adverse event anti-RBD Anti-RBD IgG association baseline candidate clinical trial Coronavirus infection COVID-19 COVID-19 vaccine COVID-19 vaccines dimeric dose doses double-blind ELISA evaluated geometric Heterologous highest homologous or heterologous homologous schedule Humoral response immunization schedule immunogenic Immunopotentiator In-vitro intensity Interaction Local Mild MOST neutralization Neutralizing Neutralizing antibodies neutralizing antibody outer membrane Panel performed Phase I Primary outcome Randomized randomly divided RBD reactogenicity receive reported Safe Safety SARS-CoV-2 second dose secondary outcome Seroconversion significantly Spike protein subject the SARS-CoV-2 three group titre toxicology two groups vaccination vaccine candidate vaccine immunogenicity Vaccines Vesicle Volunteer were used [DOI] 10.1016/j.vaccine.2022.02.029 PMC 바로가기 [Article Type] Clinical Trial
Delay in childhood vaccinations during the COVID-19 pandemicArticle Published on 2022-02-012023-07-07 Journal: Canadian Journal of Public Health = Revue Canadien [Category] COVID19(2023년), [키워드] COVID-19 immunization immunization schedule vaccination coverage Vaccinations [DOI] 10.17269/s41997-021-00601-9 PMC 바로가기
Early assessment of the safety and immunogenicity of a third dose (booster) of COVID-19 immunization in Chinese adults중국 성인을 대상으로 한 코로나19 3차 접종(부스터)의 안전성 및 면역원성 조기 평가Clinical Trial Published on 2022-02-012022-09-11 Journal: Frontiers of medicine [Category] COVID19(2023년), MERS, SARS, 임상, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 All participants analyzed Antibody titer Antibody titers BBIBP-CorV booster booster immunization booster vaccination cellular chemokine chemokines Chinese CHO cells coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 COVID-19 cytokine Cytokines dose effective elicited Endpoint exploratory study heterologous vaccine homologous or heterologous humoral immune response humoral immune responses immune responses Immunity immunization immunization schedule immunogenicity inactivated increase individuals Inducing initial majority Mild Neutralizing antibody titer neutralizing antibody titers Open-label open-label trial pandemic participant populations Protein respiratory response restored Safe Safety safety profile SARS-CoV-2 SARS-CoV-2 vaccine Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus strength Support systemic reactogenicity Trial vaccination Vaccine Vero Cell while [DOI] 10.1007/s11684-021-0914-x PMC 바로가기 [Article Type] Clinical Trial
Should We Delay the Second COVID-19 Vaccine Dose in Order to Optimize Rollout? A Mathematical Perspective롤아웃을 최적화하기 위해 두 번째 COVID-19 백신 접종을 연기해야 합니까? 수학적 관점Public Health Archive Published on 2022-01-242022-09-10 Journal: International Journal of Public Health [Category] MERS, SARS, 변종, [키워드] administer approach booster country COVID-19 COVID-19 vaccine daily dose Delay delta variant dose dose regimen doses Efficacy first dose followed by immunization schedule index Infectious disease less optimization problem pandemic public health question raise receiving reduced second second dose single dose the vaccine vaccination Vaccination strategy Vaccine vaccine doses variant [DOI] 10.3389/ijph.2021.1604312 PMC 바로가기 [Article Type] Public Health Archive
Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated VaccineSARS-COV-2 불활성 백신에 의해 유도 된 항체 및 T 세포에 의한 관심의 변이체 인식Clinical Trial Published on 2021-11-092022-08-13 Journal: Frontiers in Immunology [Category] MERS, SARS, 변종, 임상, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus addition Alpha antibodies antibody approved B.1.1.7 B.1.351 Beta Beta variant binding cellular response Cellular responses Chilean circulating variant clinical trial concern CoronaVac coronavirus D614G death rate Delta delta variant described detect dose elicited ELISPOT enrolled evaluate evaluated Gamma genetic difference genetic differences geometric mean Geometric means house human ACE2 receptor immune response immunization immunization schedule immunization schedules immunized immunogenic in-house ELISA inactivated induced Infection interferon interferon-γ-secreting T cell interferon-γ-secreting T cells Lineage microneutralization neutralization neutralize Neutralizing antibodies neutralizing antibody neutralizing capacity P.1 pandemic PBMC PBMCs Phase 3 phase 3 clinical trial promote Protective RBD Receptor binding domain Recognition reduced respiratory responsible Result SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 strain SARS-CoV-2 vaccine SARS-CoV-2 variant SARS-CoV-2 variants secreted secretion Seropositivity severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 shown significant differences spike stimulate subject T cell immunity T cells tested the RBD the SARS-CoV-2 the vaccine titers Vaccine variant variants variants of concern virus Volunteer volunteers were used Wuhan Wuhan, China [DOI] 10.3389/fimmu.2021.747830 PMC 바로가기 [Article Type] Clinical Trial
Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity다양한 선천성 면역 오류가 있는 개인의 SARS-CoV-2 백신에 대한 항체 반응Article Published on 2021-11-012022-09-11 Journal: The Journal of Allergy and Clinical Immunology [Category] MERS, SARS, 진단, 치료법, [키워드] adverse event adverse events affected age anti-S anti-S IgG anti-S IgG levels antibody Antibody Response Antibody titer Antibody titers Autoimmune B cells B-cell baseline candidiasis Care CD19 CD3 Cohort cohort of patient completion controls counseling COVID-19 COVID-19 vaccine Diagnosis dose evaluate Genetic Health Health care immune immune suppressants Immunity immunization immunization schedule immunized immunogenicity immunomodulators immunosuppressive drug immunosuppressive drugs Inborn errors inborn errors of immunity individual information Jak jak inhibitors janssen Johnson & Johnson less luciferase Luciferase immunoprecipitation system median medical records mRNA vaccine Patient patients plasma rate of seroconversion reported rituximab Safe SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccination second dose Seroconversion single dose subsequent T cells the SARS-CoV-2 therapy These data thymoma Treatment Vaccinating Vaccine was collected were measured [DOI] 10.1016/j.jaci.2021.08.016 PMC 바로가기 [Article Type] Article